Additional Treatment Related Costs Sample Clauses

Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Payee for the other Additional Treatment Related Costs as set forth in tables of Paymets bellow. Payee shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 12 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Exhibit 1 should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors. 3.
Sample 1
AutoNDA by SimpleDocs
Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Institution for the other Additional Treatment Related Costs as set forth in Exhibit 1. Institution shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 12 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Exhibit 1 3. Ďalšie náklady súvisiace s liečbou: Okrem nákladov na jedného účastníka zaplatí CRO inštitúcii aj ďalšie náklady súvisiace so skúšaním stanovené v Doložke č. 1. V súlade s článkom 12 (faktúry a platby) inštitúcia požiada o preplatenie týchto ďalších nákladov súvisiacich skúšaním a priloží k tomu podrobnú podpornú dokumentáciu alebo potvrdenky dokladajúce tieto priebežné výdaje. Akékoľvek náklady označené ako fakturovateľné v Doložke č. 1, musia byť should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors. vyfakturované CRO pri návštevách alebo v časových bodoch špecifikovaných v Doložke č. 1 a nebudú fakturované tretím stranám - pojišťovniam.
Sample 1
Additional Treatment Related Costs. In addition to the Per-Subject Costs, CRO will pay Institution for the other Additional Treatment Related Costs as set forth in Exhibit 1. Investigator shall submit requests for payment for Additional Treatment Related Costs in accordance with Section 11 (Invoices & Payments), including submission of any back-up documentation or receipts for pass- through expenses. Any costs designated as invoiceable in Exhibit 1 should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors.
Sample 1
Additional Treatment Related Costs. In addition to the Per-Subject Costs, Pfizer/CRO will pay Centerfor the other Additional Treatment Related Costs as set forth in Exhibit 1. centershall submit requests for payment for Additional Treatment Related Costs in accordance with Section 12 (Invoices & Payments), including submission of any back-up documentation or receipts for pass-through expenses. Any costs designated as invoiceable in Exhibit 1 should be invoiced at the visits or timepoints specified therein and not submitted to third party insurance payors.
Sample 1

Related to Additional Treatment Related Costs

  • CONFIDENTIAL TREATMENT REQUESTED Confidential portions of this document have been redacted and have been separately filed with the Commission.

  • Future Treatment of Unallowable Costs Unallowable Costs shall be separately determined and accounted for by Defendants, and Defendants shall not charge such Unallowable Costs directly or indirectly to any contracts with the United States or any State Medicaid program, or seek payment for such Unallowable Costs through any cost report, cost statement, information statement, or payment request submitted by Defendants or any of their subsidiaries or affiliates to the Medicare, Medicaid, TRICARE, or FEHBP Programs.

  • NATIONAL TREATMENT AND MARKET ACCESS FOR GOODS Article 201: Scope and Coverage Except as otherwise provided in this Agreement, this Chapter applies to trade in goods of a Party.

  • National Treatment In the sectors inscribed in its Schedule, and subject to any conditions and qualifications set out therein, each Party shall accord to services and service suppliers of the other Party treatment no less favourable than that it accords, in like circumstances, to its own services and service suppliers.

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • Substance Abuse Treatment Information Substance abuse treatment information shall be maintained in compliance with 42 C.F.R. Part 2 if the Party or subcontractor(s) are Part 2 covered programs, or if substance abuse treatment information is received from a Part 2 covered program by the Party or subcontractor(s).

  • Surgery Services and Mastectomy Related Treatment This plan provides benefits for mastectomy surgery and mastectomy-related services in accordance with the Women’s Health and Cancer Rights Act of 1998 and Rhode Island General Law 27-20-29 et seq. For the member receiving mastectomy-related benefits, coverage will be provided in a manner determined in consultation with the attending physician, physician assistant, or an advance practice registered nurse and the patient, for: • all stages of reconstruction of the breast on which the mastectomy was performed; • surgery and reconstruction of the other breast to produce a symmetrical appearance; • prostheses; and • treatment of physical complications at all stages of the mastectomy, including lymphedema. See the Summary of Medical Benefits for the amount you pay.

  • Confidential Treatment The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.

Time is Money Join Law Insider Premium to draft better contracts faster.